Medtronic (MDT) Other financing activities (2014 - 2026)

Medtronic (MDT) has 13 years of Other financing activities data on file, last reported at $478.0 million in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities rose 270.71% year-over-year to $478.0 million; the trailing twelve-month figure through Apr 2026 stood at $538.0 million (up 392.39% YoY), and the FY2026 full-year result was $538.0 million, up 392.39% from the prior year.
• Other financing activities advanced to $478.0 million in Q2 2026, from -$5.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $478.0 million in Q2 2026 to a low of -$719.0 million in Q1 2023.
• A 5-year average of $8.4 million and a median of -$5.0 million in 2025 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities jumped 6925.0% in 2022 and tumbled 11883.33% in 2023, its largest moves.
• Tracing MDT's Other financing activities over 5 years: stood at $170.0 million in 2022, then declined by 5.29% to $161.0 million in 2023, then tumbled by 130.43% to -$49.0 million in 2024, then soared by 89.8% to -$5.0 million in 2025, then surged by 9660.0% to $478.0 million in 2026.
• Business Quant data shows MDT's Other financing activities at $478.0 million in Q2 2026, -$5.0 million in Q1 2026, and -$5.0 million in Q4 2025.